 Partial splenic embolization effective alternative hypersplenism Splenectomy massive splenomegaly hypersplenism significant morbidity mortality partial splenic embolization PSE effective alternative PSE procedures patients mortality minimal morbidity age patients months years mean years causes splenomegaly hypersplenism cystic fibrosis cirrhosis tyrosinemia cirrhosis thalassemia hemophilia Human Immune Deficiency Virus infection chronic hepatitis portal hypertension malignant histiocytosis Wiskott-Aldrich Syndrome procedures local anesthesia sedation percutaneous femoral artery approach splenic artery Ivalon sponge particles microns spleen Splenic infarction postembolization angiograms patients improvement hematologic parameters patient cytopenia second embolization total series early mean rise leukocyte count platelet count months years Improvement blood picture persistent patients initial improvement Transient procedural complications fever pleural effusion pneumonia splenic abscess patient paralytic ileus days patient streptococcal peritonitis weeks embolization patient pancreatitis vascular compromise abdominal viscera